Analysis of mutations within the TP53 gene in patients with squamous cell carcinoma of the head and neck;Analiza wystȩpowania mutacji w obrȩbie genu TP53 u chorych na raka płaskonabłonkowego głowy i szyi

Otolaryngologia Polska

Volumn 65, Issue 2, 2011, Pages 114-121

  Golusinski, Paweł ^a   Lamperska, Katarzyna ^a   Pazdrowski, Jakub ^a   Golusinski, Wojciech ^a  

^a GREATER POLAND CANCER CENTRE   (Poland)

Author keywords

risk factor; squamous cell carcinoma; TP53 mutation

Indexed keywords

PROTEIN P53; DNA;

ALCOHOL CONSUMPTION; APOPTOSIS; ARTICLE; BLOOD; CANCER GRADING; CANCER INCIDENCE; CANCER STAGING; CANCER SURGERY; CANCER TISSUE; CELL CYCLE ARREST; CELL STRESS; CLINICAL ARTICLE; DISEASE COURSE; DNA REPAIR; GENE MUTATION; GENETIC ANALYSIS; HEAD AND NECK CARCINOMA; HUMAN; LARYNX CANCER; MOUTH CANCER; ONCOGENE; OROPHARYNX CANCER; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIMARY TUMOR; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TOBACCO; TP53 GENE; ADULT; AGED; DNA SEQUENCE; FEMALE; GENETICS; HEAD AND NECK TUMOR; MALE; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROGNOSIS; SURVIVAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; PROGNOSIS; SEQUENCE ANALYSIS, DNA; SURVIVAL ANALYSIS;

EID: 79959391652     PISSN: 00306657     EISSN: 00306657     Source Type: Journal    
DOI: 10.1016/S0030-6657(11)70640-0     Document Type: Article

References (20)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Blot WJ, McLaughlin JK, Winn DM. i in. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48: 3282-87.
3. Annertz K, Anderson H, Biorklund A. i in: Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults. Int J Cancer 2002; 101: 95-99. (Pubitemid 34833003)
4. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 2005; 103: 1843-49. (Pubitemid 40563256)
5. Nylander K, Nilsson P, Mehle C, Roos G. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck. Br J Cancer 1995; 71: 826-830.
6. El-Diery WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nature Gen 1992; 1: 45-49.
7. Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 1996; 274: 430-432. (Pubitemid 26353359)
8. Bosch FX, Ritter D, Enders C, Flechtenmacher C, Abel U, Dietz A, Hergenhahn M, Weidauer H, Bosch FX. Head and neck tumor sites differ in prevalence and spectrum of p53 alterations but these have limited prognostic value. Int J Cancer 2004, 10; 111: 530-8. (Pubitemid 39045319)
9. Le Bihan ML, Douc-Rasy S, Duvillard P, Armand JP, Riou G. High incidence of p53 alterations (mutation, deletion, over expression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein over expression in normal epithelium and in early non invasive lesions. Oncogene 1995; 10: 1217-1227.
10. Greenblatt MS, Bennett WP, Hollstein M, Haris CC. Mutations in the p53 tumor suppressor gene: clues to cancer aetiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-4878. (Pubitemid 24289415)
11. Partridge M, Costea DE, Huang X. The changing face of p53 in head and neck cancer. Int J Oral Maxillof Surg 2007; 36: 1123-38. (Pubitemid 350138394)
12. Balz V, Scheckenbach K, Gotte K, Bockmuhl U, Petersen I, Bier H. Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens. Cancer Res 2003; 63: 1188-1191. (Pubitemid 36348693)
13. Kropveld A, Rozemuller EH, Leppers FG, Scheidel KC, de Weger RA, Koole R, Hordijk GJ, Slootweg PJ, Tilanus MG. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers. Lab Invest 1999; 79: 347-353. (Pubitemid 29166450)
14. Rozemuller EH, Kropveld A, Kreyveld E, Leppers FG, Scheidel K. Sensitive detection of p53 mutation: analysis by di rect sequencing and multisequence analysis. Cancer Detect Prev 2001; 25: 109-116.
15. Hayashi K. PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl 1991; 1: 34-8.
16. Golusinski W, Olofsson J, Szmeja Z, Szyfter K, Szyfter W, Biczysko W, Hemminki K. Alteration of p53 gene structure and function in laryngeal squamous cell cancer. Eur Arch Otorhinolaryngol 1997; 254 Suppl 1: S133-7.
17. Pfeifer GP, Dennisenko MF, Olivier M. Tobacco smoke carcinogens, DNA damage and p53 mutations in smokingassociated cancers. Oncogene 2002; 21; 7435-51.
18. Brennan JA, Boyle JO, Koch WM. Association between cigarette smoking and mutation of the p53 gene in squamous - cell carcinoma of the head and neck. N Eng J Med 1995; 332; 712-7.
19. Boffetta P, Mashberg A, Winkelmann R. Carcinogenic effect of tobacco smoking and alcohol drinking on anatomic sites of the oral cvity and oropharynx. Int J Cancer 1992; 52: 530-3.
20. Lewin F, Norell SE, Johansson H. Smoking tobacco, oral snuff and alcohol in etiology of squamosus cell carcinoma of the head and neck: a population based case-referent study in Sweden. Cancer 1998; 82: 1367-75. (Pubitemid 28155400)